PharmacoEconomics

Better Analysis for Better Decisions: Facing Up to the Challenges
pp. 1039-1042(4)
Authors: Drummond, Michael F.; Sculpher, Mark J.

Recent Developments in Decision-Analytic Modelling for Economic Evaluation
pp. 1043-1053(11)
Author: Weinstein, Milton C.

Using Value of Information Analysis to Prioritise Health Research: Some Lessons from Recent UK Experience
pp. 1055-1068(14)
Authors: Claxton, Karl P.; Sculpher, Mark J.

Utility Measurement in Healthcare: The Things I Never Got To
pp. 1069-1078(10)
Author: Torrance, George W.

Pharmacoeconomics and Pharmacoepidemiology: Curious Bedfellows or a Match Made in Heaven?
pp. 1079-1086(8)
Authors: Briggs, Andrew H.; Levy, Adrian R.

Analysis Sans Frontières: Can We Ever Make Economic Evaluations Generalisable Across Jurisdictions?
pp. 1087-1099(13)
Authors: Sculpher, Mark J.; Drummond, Michael F.

`Lost in Translation': Accounting for Between-Country Differences in the Analysis of Multinational Cost-Effectiveness Data
pp. 1101-1119(19)
Authors: Manca, Andrea; Willan, Andrew R.

Information Created to Evade Reality (ICER): Things We Should Not Look to for Answers
pp. 1121-1131(11)
Authors: Birch, Stephen; Gafni, Amiram

Economic Evaluation and Decision Making in the UK
pp. 1133-1142(10)
Author: Buxton, Martin J.

Building Bridges Between Academic Research and Policy Formulation: The PRUFE Framework - an Integral Part of Ontario's Evidence-Based HTPA Process
pp. 1143-1156(14)
Authors: Goeree, Ron; Levin, Leslie

Economic Evaluations in the Canadian Common Drug Review
pp. 1157-1162(6)
Author: Laupacis, Andreas

Economic Evaluation in the US: What is the Missing Link?
pp. 1163-1168(6)
Authors: Neumann, Peter J.; Sullivan, Sean D.